Imaging-Based Treatment Modifications Only Used in 15 Percent of Neoadjuvant Systemic Therapy Trials for Breast Cancer

A systematic review of 147 clinical trials assessing neoadjuvant systemic therapy for breast cancer also revealed that mid-treatment imaging was utilized in 56 percent of the studies.

Read the full article on diagnosticimaging.com